top of page

why? Did the Kobe District Court decide to start bankruptcy proceedings?

Alblast's decision to start bankruptcy proceedings

Alblast USA's patent, which was changed by Motohiro Kasahara at the same time as the fabrication trial organized by Motohiro Kasahara of the Tokyo District Court.

On November 15, 2011, the Kobe District Court responded to the bankruptcy filing filed by Zen Kitagawa, who was a former representative of Alblast Co., Ltd. The district court has decided to start bankruptcy proceedings.

This fact, no matter who thinks, is "an unusual trial in the world. Even if you have a common sense brain, it was a strange and mysterious decision that truly received the bankruptcy filing of the demented person and caused enormous damage to the shareholders. For example, the content is understandable by anyone.

However, the Kobe District Court decided to start bankruptcy proceedings.

An unprecedented trial in the world, in which a doctor submits a medical certificate that is diagnosed as impossible to do any work, accepts the bankruptcy of a person on leave, and makes a decision to start!


This happened just 30 days before Alblast USA, which held about 30% of the shares, was approved for listing by the New York Securities Commission in the United States.


News article about the retirement of Akira Kitagawa

Medical certificate of all Kitagawa's dementia submitted by Motohiro Kasahara

Therefore, all shareholders and related parties


"Where is this going bankrupt? Alblast holds a 30% stake in a company that will become a reverse marketer in the United States a month later. You can't go bankrupt! You own an asset, don't you? Where is the court? 』\

I was shocked.


This is because both the lawyer of the trial filed by the Turkish director of Stemcell Science, which should have nothing to do with it, and the lawyer of the bankruptcy filing filed by Zen Kitagawa of Alblast, both are Motohiro Kasahara of AK Law Offices. The fact that it is, even those who are not familiar with the law, are distrustful.


Many shareholders were similar.


In particular, the anger of the shareholders of the listed company Forty Cell Bioscience, which was a listed company and had invested about 18 billion yen, has not yet subsided.


Looking at the statute of limitations, there is no doubt that it is an unfinished story among stakeholders and shareholders.


The most mysterious thing was when I first talked to Motohiro Kasahara.

About a week before I received the call from Motohiro Kasahara, I was told the following story by Shigeru Kinoshita.


Shigeru Kinoshita "It seems that the Foundation is also in contact with the directors of Stem Cell Science, so Alblast will go bankrupt due to time constraints. Ryan, too, will be scooped up if you're not careful. 』\


About a week after a mysterious conversation about whether or not this blackmail could be called, I got a call from Motohiro Kasahara, who is a lawyer of Chimaki Furusawa (Turkish name Ouz Memet) who was a director of Stem Cell Science. It was.


It was just as Shigeru Kinoshita said, so he said, "Is the director of Stem Cell Science, which the Foundation was in contact with, Furusawa ?! I understood, but Shigeru Kinoshita said, [Alblast will go bankrupt. ] And [Can you scoop your feet? ] I still didn't understand the meaning at this time.


It was an unbelievable story that lies and forged content would pass through at the trial, and I was surprised that Furusawa so far misrepresented his identity and talked about the forged content.


Currently, I understand what type of lawyer Motohiro Kasahara is.


Since I have evidence of identity fraud and document fabrication, I was able to understand the personalities of Kasahara and Kinoshita.


Motohiro Kasahara, one of the people who stole the patent.

Chimaki Furusawa, who Kasahara defends as an agent.


Given this fact, anyone can understand that the purpose of both of them was patent.

Moreover, after the decision of the Tokyo District Court, which is the fabrication trial of Furusawa and Kasahara, Motohiro Kasahara and Zen Kitagawa filed for bankruptcy as if they were waiting for the decision.


Everyone, including shareholders, said, "Oh. Is that so? Was this forgery trial by Furusawa necessary for the bankruptcy of Alblast? When I noticed, it was after the bankruptcy filing was filed by the same lawyer, Motohiro Kasahara.


A lawyer involved in the trial by Chimaki Furusawa (Turkish name Ouz Memet), a former director of Stem Cell Science, the trial by Zen Kitagawa, a former director of Alblast, and the takeover of US patents by Alblast USA. why? The composition is that all of them are the same Motohiro Kasahara, and the tissue that pulls the thread on the back can be seen through.


The composition is that the same lawyer, who is also a lawyer specializing in patents, is involved.

Moreover, I'm not sure if it's a lie, but when I searched for the name of Motohiro Kasahara on the Internet, he said, "A lawyer specializing in patent law. ] Is a lot of content.

It is said that it is a manga patent, but for our company, which actually hijacked the patent, "I see. I understand I understand. It is a content that nods.


Furthermore, the new company planned by the Kobe Advanced Medical Promotion Foundation, where Yoshiko Nakajima, a remnant of Stemcell Science, and Shigeru Kinoshita, a professor at Kyoto Prefectural University, were affiliated with Kasahara. is.


Chimaki Furusawa (Turkish name Ouz Memet), who blocked the listing of Stem Cell Science, was involved in blocking the listing of Stem Cell Science (reverse merger), and caused a great deal of damage to shareholders, once again. Blocking the listing (reverse merger) of Alblast USA, which was involved, in the United States!

I think it was inspired by the Foundation's Yoshiko Nakajima, but every time I told American shareholders about this series of events, they said, "It's an incredible story. It's like a movie. "Is called.


Indeed, too many bizarre and bizarre things have happened.


Especially disastrous was the sons of Ryan and his wife, who fell into a plant-human state with a plastic bag on their heads two days after December 26, 2007, when they decided to accuse police of falsifying Stemcell Science's papers. After that, in the same month when Zen Kitagawa and Motohiro Kasahara filed for bankruptcy of Alblast, it was decided that the director of the hospital where his son was hospitalized would suddenly change to Mitsuko Yuzawa, a group of Shigeru Kinoshita. After that, Ryan and his son were abused as if they were being tested. (There is evidence of video recording tape.)


The other day, the doctor at this hospital finally said, "Everything was abused under the direction of Director Mitsuko Yuzawa of Nihon University Hospital. Isn't it understandable who was the mastermind behind the above content by confessing?


The incident broke out, and the film's script was "The method of continuing to abuse an 11-year-old child using the torture used by CIA terrorists is a professional and rewarding case. "It is said that.

Cases related to the decision of the Kobe District Court

Stem Cell Science

Medical case at National Defense Medical College Hospital

Nihon University Medical Case

bottom of page